EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

The BMDC model, a performant cell‐based test to assess the sensitizing potential and potency of chemicals including pre/pro‐haptens

Fabrice Battais iD, Isabelle Langonné, Samuel Muller, Julianne Mathiot, Amélie Coiscaud, Adrien Audry, Aurélie Martin Remy, Isabelle Sponne, Mélanie Mourot-Bousquenaud iD

Contact Dermatitis · 2024

DOI: 10.1111/cod.14439 ↗

At a glance

Journal article in Contact Dermatitis, 2024. Written by Fabrice Battais and 8 co-authors. Institution: French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), Toxicology and Biomonitoring Division, Vandoeu…. Major MEDLINE topics: Dermatitis, Allergic Contact. Cited 10 times so far (Crossref); 79 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Chemical‐induced allergies at workplace represent a significant occupational health issue. These substances must be properly identified as sensitizers. In previous studies, an original model using mouse bone marrow‐derived dendritic cells (BMDC) was developed for this purpose.

Objectives

The aim of this study was to evaluate the predictive capacity of the BMDC model with a large panel of sensitizers (including pre‐ and pro‐haptens) and non‐sensitizers.

Methods

The readout from the BMDC model is based on expression levels of six phenotypic markers measured by flow cytometry.

Results

The results indicate that 29 of the 37 non‐sensitizers, and 81 of the 86 sensitizers were correctly classified compared to the Local Lymph Node Assay (LLNA). Statistical analysis revealed the BMDC model to have a sensitivity of 94%, a specificity of 78%, and an accuracy of 89%. The EC2 (Effective Concentration) values calculated with this model allow sensitizers to be categorized into four classes: extreme, strong, moderate and weak.

Conclusions

These excellent predictive performances show that the BMDC model discriminates between sensitizers and non‐sensitizers with outstanding precision equal to or better than existing validated alternative models. Moreover, this model allows to predict sensitization potency of chemicals. The BMDC test could therefore be proposed as an additional tool to assess the sensitizing potential and potency of chemicals.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactMiceAnimalsHaptensLocal Lymph Node AssayFlow CytometryAllergens

Author keywords

bone marrow-derived dendritic cellschemical allergensin vitro assaypotencysensitization

Substances

HaptensAllergens

Authors and institutions

  • French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), Toxicology and Biomonitoring Division, Vandoeuvre les Nancy, France.

ORCID profiles: Fabrice Battais, Mélanie Mourot-Bousquenaud

Cite

APA

Battais, F., Langonné, I., Muller, S., Mathiot, J., Coiscaud, A., Audry, A., Remy, A. M., Sponne, I., & Mourot-Bousquenaud, M. (2024). The BMDC model, a performant cell‐based test to assess the sensitizing potential and potency of chemicals including pre/pro‐haptens. Contact Dermatitis. https://doi.org/10.1111/cod.14439

Vancouver

Battais F, Langonné I, Muller S, Mathiot J, Coiscaud A, Audry A, et al. The BMDC model, a performant cell‐based test to assess the sensitizing potential and potency of chemicals including pre/pro‐haptens. Contact Dermatitis. 2024. doi:10.1111/cod.14439

BibTeX
@article{Battais2024,
  author = {Battais, Fabrice and Langonné, Isabelle and Muller, Samuel and Mathiot, Julianne and Coiscaud, Amélie and Audry, Adrien and Remy, Aurélie Martin and Sponne, Isabelle and Mourot-Bousquenaud, Mélanie},
  title = {The BMDC model, a performant cell‐based test to assess the sensitizing potential and potency of chemicals including pre/pro‐haptens},
  journal = {Contact Dermatitis},
  year = {2024},
  doi = {10.1111/cod.14439}
}
Start for free →